INSIGHTS ON ENTERPRISE SOLUTIONS
-
![Thermo - bioprocessing evolve]( "How Can Bioprocessing Professionals Evolve Their Manufacturing For Greater Flexibility And Efficiency?")
How Can Bioprocessing Professionals Evolve Their Manufacturing For Greater Flexibility And Efficiency?Manufacturing flexibility is now a competitive differentiator. Here's how single-use technologies are reshaping bioprocessing facility design, scalability, and sustainability strategy.
-
![GettyImages-1453524887-scientist-in-lab-with-computer-and-microscope]( "3 Innovations For Reducing Risk In Continuous Downstream Bioprocessing")
3 Innovations For Reducing Risk In Continuous Downstream BioprocessingBatch-to-continuous transitions in downstream bioprocessing carry real risks. Here's how advanced analytics, smarter buffer strategies, and single-use systems are changing that calculus.
-
![Syringe–Cartridge Filling Line In Action]( "Syringe–Cartridge Filling Line In Action")
Syringe–Cartridge Filling Line In ActionDesigned for medium‑ to high‑volume ISO syringes and cartridges, this high‑speed filling line delivers tight manufacturing control, supports larger batches, and meets growing biologics demand.
-
![GettyImages-1368887558-assay-bioassay-well]( "Cell Based Potency Assays: De-Risk Your Path With An Experienced CDMO")
Cell Based Potency Assays: De-Risk Your Path With An Experienced CDMOThorough characterization is key to unlocking the potential of antibody-based therapeutics. Leveraging a CDMO's extensive capabilities and expertise can allow you to navigate the biopharmaceutical development landscape.
-
De-Risk Nucleic Acid Therapeutics Through Strategic Outsourcing4/20/2026
Bringing a nucleic acid therapy to market requires specialized formulation and development knowledge. Innovators need rigorous analytical and formulation strategies to achieve stability and quality.
-
Where Sourcing Meets Science: Smarter Collaboration, Better Outcomes4/20/2026
See how collaboration-driven raw material control reduces variability, improves cell culture performance, and delivers measurable cost and productivity gains in biotherapeutic manufacturing.
-
Improving CD Media Titers With Nu-Tek Peptones4/17/2026
Adding 0.2% soy peptone to chemically defined media increases CHO IgG production by 30–60%. This animal-free supplementation enhances titers while maintaining high process control.
-
Yeast Extracts: Improving Expression4/17/2026
Yeast extract improves E. coli protein production by over 50%, boosts desired protein attributes 4X, and offers a secure animal-free nutrient source.
ENTERPRISE SOLUTIONS
-
![GettyImages-1158724314-electorphoresis-hand-filling-cell]( "Syracuse Bio Campus: Every Detail. Built Around You")
The Syracuse Bio Campus offers U.S.-based mammalian production and bioconjugation, supporting development through commercial manufacturing with regulatory expertise and tailored solutions.
-
![GettyImages-1938951579-automation-filling-bottles-modern-robot-manufacturing]( "Aseptic Fill Finish")
One of the few CDMOs offering sterile fill, device manufacturing, and final assembly at one site — combining expertise, scale, and flexibility for clinical, commercial, and niche production.
-
![GettyImages-1398569507 regulatory]( "U.S. Pharmaceutical Tariffs (Section 232): Implications & Actions")
New U.S. tariffs are reshaping pharma manufacturing. Early action to assess exposure and pursue onshoring can cut risk, protect margins, and strengthen supply chains.
-
![osd-manufacturing-GettyImages-2145984822]( "Scalable Solutions For High Potent OSD Manufacturing")
High potent oral solid dose manufacturing demands rigorous containment, scalable processes, and regulatory alignment. Learn how closed systems, advanced facilities, and flexible batch strategies support safe development and reliable commercial supply.
-
Single‑site ADC manufacturing integrates antibody production, conjugation, and quality systems to reduce complexity, accelerate timelines, and support scalable clinical‑to‑commercial development.
